Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer.

Yuan Yuan Susan E YostYujie CuiChristopher RuelMireya MurgaAileen TangNorma MartinezDaniel SchmolzeJames WaismanNiki PatelLalit VoraLusine TumyanMari BozoghlanianDaphne StewartPaul H Frankel

Published in: The oncologist (2023)

NCT03853707.

Keyphrases

phase iii
phase ii study
open label
clinical trial
phase ii
squamous cell carcinoma
small cell lung cancer
locally advanced
double blind
placebo controlled
study protocol
radiation therapy
randomized controlled trial
metastatic colorectal cancer
metastatic breast cancer